tradingkey.logo

Apyx Medical Corp

APYX
3.680USD
+0.190+5.44%
交易中 美東報價延遲15分鐘
139.18M總市值
虧損本益比TTM

Apyx Medical Corp

3.680
+0.190+5.44%

關於 Apyx Medical Corp 公司

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.

Apyx Medical Corp簡介

公司代碼APYX
公司名稱Apyx Medical Corp
上市日期Jul 22, 1983
CEOGoodwin (Charles D)
員工數量220
證券類型Ordinary Share
年結日Jul 22
公司地址5115 Ulmerton Rd
城市CLEARWATER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33760-4004
電話18005372790
網址https://apyxmedical.com/
公司代碼APYX
上市日期Jul 22, 1983
CEOGoodwin (Charles D)

Apyx Medical Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
Domestic
7.78M
68.37%
International
3.60M
31.63%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
8.14%
Archon Capital Management LLC
8.00%
Vanderfelt (William Weeks)
7.70%
Royce Investment Partners
6.03%
Vizirgianakis (Stavros G)
4.26%
其他
65.87%
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
8.14%
Archon Capital Management LLC
8.00%
Vanderfelt (William Weeks)
7.70%
Royce Investment Partners
6.03%
Vizirgianakis (Stavros G)
4.26%
其他
65.87%
股東類型
持股股東
佔比
Hedge Fund
17.02%
Individual Investor
13.42%
Investment Advisor
11.62%
Investment Advisor/Hedge Fund
8.99%
Private Equity
0.37%
Family Office
0.23%
Research Firm
0.10%
Venture Capital
0.05%
其他
48.19%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
93
15.65M
47.11%
--
2025Q3
106
16.17M
54.10%
-179.30K
2025Q2
111
16.35M
54.58%
+38.20K
2025Q1
115
16.92M
61.27%
-6.24M
2024Q4
121
17.05M
55.05%
+3.13M
2024Q3
126
13.93M
65.05%
-228.66K
2024Q2
141
15.10M
68.01%
-305.66K
2024Q1
168
15.41M
70.58%
-9.04M
2023Q4
180
18.49M
72.63%
-941.37K
2023Q3
175
19.43M
74.54%
-988.75K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Nantahala Capital Management, LLC
3.34M
8.83%
+80.00K
+2.46%
Jun 30, 2025
Archon Capital Management LLC
3.28M
8.68%
-15.26K
-0.46%
Jun 30, 2025
Vanderfelt (William Weeks)
3.16M
8.35%
--
--
Jun 23, 2025
Royce Investment Partners
2.44M
6.45%
-85.76K
-3.40%
Jun 30, 2025
Vizirgianakis (Stavros G)
1.75M
4.62%
--
--
Jun 23, 2025
The Vanguard Group, Inc.
1.48M
3.9%
--
--
Jun 30, 2025
Silverberg Bernstein Capital Management, LLC
986.50K
2.61%
+89.77K
+10.01%
Sep 30, 2025
Commonwealth Financial Network
663.54K
1.75%
+78.00K
+13.32%
Jun 30, 2025
Horizon Kinetics LLC
615.00K
1.63%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
495.99K
1.31%
+6.87K
+1.40%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.02%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
佔比0.02%
Avantis US Equity ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Apyx Medical Corp的前五大股東是誰?

Apyx Medical Corp的前五大股東如下:
Nantahala Capital Management, LLC
持有股份:3.34M
佔總股份比例:8.83%。
Archon Capital Management LLC
持有股份:3.28M
佔總股份比例:8.68%。
Vanderfelt (William Weeks)
持有股份:3.16M
佔總股份比例:8.35%。
Royce Investment Partners
持有股份:2.44M
佔總股份比例:6.45%。
Vizirgianakis (Stavros G)
持有股份:1.75M
佔總股份比例:4.62%。

Apyx Medical Corp的前三大股東類型是什麼?

Apyx Medical Corp 的前三大股東類型分別是:
Nantahala Capital Management, LLC
Archon Capital Management LLC
Vanderfelt (William Weeks)

有多少機構持有Apyx Medical Corp(APYX)的股份?

截至2025Q4,共有93家機構持有Apyx Medical Corp的股份,合計持有的股份價值約為15.65M,占公司總股份的47.11% 。與2025Q3相比,機構持股有所增加,增幅為-6.99%。

哪個業務部門對Apyx Medical Corp的收入貢獻最大?

在FY2025Q2,--業務部門對Apyx Medical Corp的收入貢獻最大,創收--,占總收入的--% 。
KeyAI